Life Molecular Imaging

Life Molecular Imaging

Germany - Berlin
Biotechnology
WebsiteLinkedInCareers Page

Focus: Molecular Imaging

Life Molecular Imaging is a life sciences company focused on Molecular Imaging.

NeurologyOncologyCardiovascular
Open Jobs
1

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT0407387518F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis
N/A
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
Alzheimer Disease
N/A
Clinical Trials (1)
NCT05326009A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
N/A
Phase 1
Clinical Trials (1)
NCT05337774Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
Phase 1
Phase 1
Clinical Trials (1)
NCT01089998PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
Phase 1
[18F] PI-2620 Tau Ligand
Chronic Traumatic Encephalopathy
Phase 1
Clinical Trials (1)
NCT05490576Tau And Connectomics In TES Study
Phase 1
Phase 1
Clinical Trials (1)
NCT01103310Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation
Phase 1
Phase 1
Clinical Trials (1)
NCT01297088PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.
Phase 1
PET tracer
Neoplasms
Phase 1
Clinical Trials (1)
NCT01186601Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer
Phase 1
Florbetaben F18
Cardiac Amyloidosis
Phase 1
Clinical Trials (1)
NCT06790394Test-retest Study With [18F]FBB in Cardiac Amyloidosis
Phase 1
Phase 1
Clinical Trials (1)
NCT05187546Test-retest Study With [18F]PI-2620 in PSP-RS and NDC
Phase 1
18F-FSPG
Brain Cancer
Phase 1
Clinical Trials (1)
NCT02370563PET Imaging of Intracranial Cancers With 18F-FSPG
Phase 1
Phase 1
Clinical Trials (1)
NCT02531360Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
Phase 1
Phase 1
Clinical Trials (1)
NCT01205321PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT01287845PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT01138111Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients
Phase 1
Phase 1
Clinical Trials (1)
NCT01153607Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers
Phase 1
[18F]-PI2620
Alzheimer Disease
Phase 1
Clinical Trials (1)
NCT04715750Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity
Phase 1
Phase 1
Clinical Trials (1)
NCT02469376Evaluation of a New Imagingtechnologie for Thrombosis
Phase 1
Phase 1/2
Clinical Trials (1)
NCT02483884PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
Phase 1/2
Phase 2
Clinical Trials (1)
NCT00750282Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers
Phase 2
Florbetaben
Down Syndrome
Phase 2
Clinical Trials (1)
NCT00928304Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
Phase 2
Nilotinib BE 84mg
Alzheimer Disease
Phase 3
Clinical Trials (1)
NCT05143528Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease
Phase 3
Phase 3
Clinical Trials (1)
NCT01020838Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
Phase 3
[18F]florbetaben
Cardiac Amyloidosis
Phase 3
Clinical Trials (1)
NCT05184088Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Phase 3
[18F]PI-2620
Alzheimer Disease
Phase 3
Clinical Trials (1)
NCT05641688[18F]PI-2620 Phase 3 Histopathological Study
Phase 3

Open Jobs (1)

International License Partner Quality Specialist

Quality Assurance
1w ago
Interview Prep Quick Facts
Portfolio: 25 clinical trials
Open Roles: 1 active job

Hiring Trend

Stable
1
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles